ABIGAIL MOOS: Open Payments
NPI 1558556886 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 9 payments from 8 companies in 2025. Trend: 2023 $583 · 2024 $269 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $47 |
| Medtronic, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: CARDIOMEMS, PORTICO, AFFERA MAPPING SYSTEM, LEQVIO, REPATHA, WATCHMAN FLX, ELIQUIS, FARXIGA.
Industry payments across KS — which companies pay providers there.
